Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline, histidine and glycine-rich protein 1 (PHGR1) is a small, glycosylated protein expressed primarily in mature epithelial cells of the gastrointestinal (GI) tract, especially in the colon and small intestine[1][2][3][5]. PHGR1 localizes to both the cytoplasm and nucleus, with nuclear localization increasing during epithelial cell differentiation[2][5]. Transcriptomic and gene ontology analyses indicate roles in intracellular transport and metabolic processes in GI epithelial cells[1][2]. Knockdown of PHGR1 leads to significant changes in gene expression related to transport, localization, and metabolic functions[2]. PHGR1 is not a receptor, enzyme, transporter, or classical therapeutic target, but it is considered a promising biomarker for detection of lymph node metastases in colorectal cancer and may have utility in cancer diagnostics[1][2]. There is no current evidence of direct drug interactions or known safety concerns described for this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline, histidine and glycine-rich protein 1 (PHGR1).